About 200 reports

  • DRUG INFUSION PUMP - PRODUCT DESCRIPTION

If approved, ITCA ## would represent a new twice-yearly delivery system of a glucagon-like peptide-## (GLP-##) receptor agonist for maintenance therapy of type ## diabetes.

  • Clinical Trial
  • Injectable Delivery
  • Therapy
  • United States
  • Medtronic, Inc.
  • Jun 22, 2020: Verastem Oncology announces presentation of preclinical data supporting the combination of VS-6766 and Defactinib in metastatic uveal melanoma
  • CKI-27 - DRUG PROFILE

Uveal melanoma arises from the melanin-producing cells in the eye, similar to how it arises in cutaneous melanoma.

  • Cancer
  • Colorectal Cancer
  • Targeted Therapy
  • Therapy
  • Bayer AG
  • CRYOTHERAPY MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • 8.2 HOSPITALS & SPECIALTY CLINICS

CRYOABLATION IS USED TO TREAT BONE CANCER, CERVICAL CANCER, AND CANCERS OF THE EYE, KIDNEY, LIVER, LUNGS, AND PROSTATE.

  • Hospital
  • North America
  • United States
  • CooperSurgical, Inc.
  • Medtronic, Inc.
  • Global Radiation Therapy Market By Application, By Value
  • Global Radiation Therapy Market By Application, By Value

During their lifetime, one in five men and one in six women worldwide develop cancer, and one in eight men and one in eleven women die from the illness.

  • Cancer
  • World
  • Market Size
  • Accuray Incorporated
  • IsoRay, Inc.
  • REGENERON PHARMACEUTICALS INC
  • BIRCH POLLEN ALLERGY - PIPELINE BY S-TARGET THERAPEUTICS GMBH, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Allergy
  • Chronic Disease
  • Therapy
  • Vaccine
  • Anergis SA
  • Nov 23, 2015: Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
  • Dec 01, 2015: Cellceutix Receives Rare Pediatric Disease Designation From FDA for Kevetrin for the Treatment of Retinoblastoma

Retinoblastoma is an eye cancer that begins in the retina.

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Cellceutix Corporation
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2020
  • REGENERON PHARMACEUTICALS INC

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Analgesic
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • Pfizer Inc.
  • PHARMABCINE INC
  • PIPELINE BY MOMENTA PHARMACEUTICALS INC, H2 2020

It is a ligand for VEGFR-## (vascular endothelial growth factor receptor ##) and NRP-## (neuropilin-##).

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • 5.2 MARKET DYNAMICS

For instance: In March 2019, researchers from Development, Ageing and Disease Theme, UCL Institute of Ophthalmology, and University College London (UK) collaborated in order to study the importance of RNA-sequencing in ophthalmology research for eye cancer.

  • Biotech Diagnostics
  • Genomics
  • Molecular Diagnostics
  • RNA
  • RNAi Technology
  • REGENERON PHARMACEUTICALS INC
  • RETINOPATHY OF PREMATURITY - PIPELINE BY RECORDATI SPA, H1 2020

The drug candidates by inhbiting TREM-## prevent the inflammatory process and cancer progression.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PHARMABCINE INC
  • PIPELINE BY MOMENTA PHARMACEUTICALS INC, H1 2020

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY PFIZER INC, H1 2020
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Analgesic
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • Pfizer Inc.
  • REGENERON PHARMACEUTICALS INC
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2020

IT WAS ALSO UNDER DEVELOPMENT FOR COLORECTAL CANCER, OVARIAN CANCER, HEPATOCELLULAR CARCINOMA, SOLID TUMOR, RECURRENT GLIOBLASTOMA MULTIFORME (GBM) AND EYE DISEASES, RENAL CELL CARCINOMA, MACULAR TELANGIECTASIA TYPE ##, DIABETIC MACULAR EDEMA (DME OR DIABETEIC

  • Biosimilar
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY PHARMABCINE INC, H1 2020
  • PHARMABCINE INC

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Eye Disease
  • Ophthalmology
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • 9.3.7.1 India Confocal Microscopes Market Revenue and Forecasts to 2027 (US$ Mn)
  • India Confocal Microscopes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure ##. ##.

  • Diagnostic Imaging
  • Medical Device
  • Microscope
  • Forecast
  • Market Size
  • Products under Development by Companies, H2 2019 (Contd..1), H2 2019
  • Traumatic Pain

It was also under development for cancer pain and local pain.

  • Cardiovascular Disease
  • Heart Failure
  • Hospital
  • Therapy
  • Novartis AG
  • 6.1 Bayer
  • Bayer Sales and Net Income (2014-2018)

Within the prescription medicines, the sales grew for eye medicine, cancer drugs and pulmonary hypertension treatment medicine.

  • Pharmaceutical
  • Vaccine
  • Veterinary Healthcare
  • World
  • Merck & Co., Inc.
  • 13 GLOBAL 3D PRINTING MARKET- BY END-USER
  • 15 END USER

For instance, in 2014, researchers, using facial scanning software and ##D printing, came up with a fast and economical way to make facial prostheses for patients who had undergone surgeries for eye cancer.

  • 3D Printing
  • Manufacturing
  • World
  • Market Size
  • Stratasys Ltd.
  • REGENERON PHARMACEUTICALS INC
  • FAMILIAL AMYLOID NEUROPATHIES - PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2020

Three (##. ##percent) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Endocrine Disease
  • Neurology
  • Therapy
  • Type 2 Diabetes
  • Alnylam Pharmaceuticals, Inc.
  • PIPELINE BY PRECISION BIOSCIENCES INC, H1 2020
  • PIPELINE BY PROTHENA CORP PLC, H1 2020

Three (##. ##%) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Cardiology
  • Endocrine Disease
  • Hospital
  • Therapy
  • Alnylam Pharmaceuticals, Inc.
  • R&D Progress Research and Development Brief
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT ICAM-1 FOR RETINAL DISEASES AND CANCER - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY NEUROTEZ INC, H2 2019
  • PIPELINE BY JYANT TECHNOLOGIES INC, H2 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Dermatological Condition
  • Diabetes
  • Pharmaceutical
  • Therapy
  • United States
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

ONE DROP OF ## G/ ML LUBRICIN IS EFFECTIVE IN REDUCING THE INSTANTANEOUS SYMPTOMS OF DRY EYE DISEASE FOR UP TO ## MINUTES.

  • Hospital
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • TaiwanJ Pharmaceuticals Co., Ltd.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

It develops antagonists for orphan nuclear receptor steroidogenic factor-##, to treat adrenocortical cancer and Cushing' s syndrome.

  • Autoimmune Disease
  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT ICAM-1 FOR ONCOLOGY AND RETINAL DISEASES - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY PROCLARA BIOSCIENCES INC, H2 2019
  • PROTHENA CORP PLC

Three (##. ##%) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Endocrine Disease
  • Hospital
  • Pharmaceutical
  • Therapy
  • Alnylam Pharmaceuticals, Inc.
  • PROTHENA CORP PLC
  • FAMILIAL AMYLOID NEUROPATHIES - PIPELINE BY PROTHENA CORP PLC, H2 2019

Three (##. ##percent) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Endocrine Disease
  • Hospital
  • Neurology
  • Therapy
  • Type 2 Diabetes
  • PIPELINE BY NEUROTEZ INC, H1 2020
  • PIPELINE BY NEURONANO PHARMA INC, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Dermatological Condition
  • Diabetes
  • Pharmaceutical
  • Therapy
  • United States
  • PFIZER INC
  • FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (MYOSITIS OSSIFICANS PROGRESSIVA) - PIPELINE BY PFIZER INC, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • BioCryst Pharmaceuticals, Inc.
  • ANTISENSE RNAI OLIGONUCLEOTIDES TO INHIBIT HIF-1 ALPHA FOR ONCOLOGY AND RETINAL DISEASE - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Dermatological Condition
  • Pharmaceutical
  • Therapy
  • United States
  • Cerulean